Navigation Links
Stryker Launches VersiTomic G-Lok™
Date:7/7/2011

SAN DIEGO, July 7, 2011 /PRNewswire/ -- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine its new G-Lok implant has joined its comprehensive VersiTomic portfolio for ACL/PCL reconstruction.

Built upon the same versatile, anatomic, and reliable advanced technology as products currently in the VersiTomic portfolio, the VersiTomic G-Lok is designed to provide suspension fixation of soft tissue to bone during orthopaedic reconstruction procedures.  

The G-Lok's unique rod design creates a spring-like action which allows the G-Lok to automatically deploy on the cortical surface. G-Lok's loop material is made from the latest technology in high performance medical-grade fiber from Dyneema Purity, available in multiple loop sizes, and is designed to increase creep resistance and enhance strength(1). In addition, G-Lok XL is available to provide an additional 5mm in length and 1mm in width to the G-Lok.

"Our VersiTomic platform  is designed to provide surgeons with the flexibility and versatility they need to create a more anatomic ACL or PCL reconstruction while allowing them to customize their technique to the patient," said Matt Moreau, Vice President & General Manager, Stryker Joint Preservation.

G-Lok joins Stryker's VersiTomic Flexible Reaming System whose puzzle piece technology allows for anatomically placed tunnels without the need to hyperflex the knee, and its Biosteon Biocomposite Interference Screws, with over nine years of clinical use, for a comprehensive solution to ACL/PCL reconstruction.

To see a demonstration of these products, please visit Stryker at booth #503 at AOSSM.

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes, joint preservation products and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

(1) DSM0972- Product Leaflet Dyneema Purity® UGContact:Jeanine GuilfoyleStryker Orthopaedics201-831-6277jeanine.guilfoyle@stryker.com  
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
2. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
3. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
4. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
5. Stryker Declares a $0.18 Per Share Quarterly Dividend
6. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
7. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
8. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
9. TriMed, Inc. Announces Licensing Agreement with Stryker
10. Stryker Increases Expected 2010 Results and Provides 2011 Outlook
11. Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Global Paclitaxel Market 2016 Industry Research ... and the Paclitaxel analysis in this study is supported ... its players. This is the latest Paclitaxel ... current state of the industry while providing a basic ... industry chain structure. The Paclitaxel market analysis is provided ...
(Date:5/23/2016)... 2016 According to market ... Growth and Demand Forecast to 2022 - Industry ... Application (Drug Discovery and Development, Proteomics, Clinical Testing, ... Science and Biotechnology, Academic and Research Institute, Hospitals ... global mass spectrometry market was valued ...
(Date:5/23/2016)... JERUSALEM , May 23, 2016 ... DNA for detection of multiple diseases; ,Technology to be ... Yissum Research Development Company of the ... entered into a research agreement with Aurum Ventures MKI, the ... the development of a new diagnostic approach for early ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips may ... to popular cosmetic improvement efforts. Record numbers of clients now ask about lip plumping ... pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The trend ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In 1980, ... running plumbing calls throughout the beach community. His vision to grow the company was ... and ensuring they maintain the highest level of training and customer service. Over 35 ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... weekend to host their second pop-up shop for three consecutive weekends. The pop-up ... to the Santa Barbara community, a community full of women who appreciate the ...
(Date:5/25/2016)... ... 26, 2016 , ... The 12th session of the Silicon Valley BioTalks will ... Palo Alto, CA. This Bay Area biotech event will focus on “Setting Up Early ... the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization (CRO) Experien Group, and Electronic ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Furthering its ... amateur athletics, The National Center for Drug Free Sport (Drug Free Sport®) is excited ... This conference, to be held July 12 – 13 in Kansas City, MO, will ...
Breaking Medicine News(10 mins):